There is no large internal CMC or manufacturing organization: you will execute through CDMOs, contract laboratories, and specialist consultants, while remaining personally engaged in the technical details—including reviewing development reports, interrogating a chromatogram, troubleshooting technical issues, and authoring Module 3.Candidates will have a strong expertise in antibody-based multi-specifics — bispecifics and, ideally, tri-specifics. End-to-End Product Development & Technical Operations: Lead the integrated CMC strategy from developability and candidate selection through cell line development, upstream and downstream process development, analytical development and characterization, formulation, drug substance and drug product manufacture, stability, comparability, clinical supply, scale-up, and technology transfer into GMP manufacturing.